Seoul St. Mary's Hospital Partners With Ion Beam Applications on Major Proton Therapy Expansion

The Catholic University of Korea’s Seoul St. Mary’s Hospital has inked a significant deal with Ion Beam Applications to bring advanced proton therapy capabilities to Seoul. The Belgian medical device company will install a Proteus PLUS system at the facility, marking a substantial investment in cutting-edge cancer treatment technology.

Contract Scope and Investment Scale

The partnership centers on deploying a three-room Proteus PLUS configuration complete with a multi-year service and maintenance package. Ion Beam Applications typically values such comprehensive installations between 80 million euros and 100 million euros, reflecting the sophisticated nature of modern proton therapy infrastructure.

The agreement notably includes provisions for DynamicARC beam delivery technology, pending successful regulatory approval. This advanced capability will enhance the precision and efficacy of treatment protocols once implemented.

Facility Specifications and Timeline

Seoul St. Mary’s Hospital envisions an impressive healthcare infrastructure spanning eight floors—incorporating both above-ground and underground levels—dedicated to the proton therapy center. The entire facility will occupy 37,851 square meters of operational space, positioning it as a major regional cancer treatment hub.

Patient treatment is slated to commence by the end of 2029, providing Seoul St. Mary’s Hospital adequate time to complete construction, integrate systems, and prepare clinical teams for operations.

Market Significance

This contract underscores growing momentum in Asian healthcare systems toward adopting proton therapy as a preferred treatment modality. The investment demonstrates both the hospital’s commitment to advanced oncology care and Ion Beam Applications’ expanding footprint in high-growth markets.